Literature DB >> 31014970

Practice Variation in the Evaluation and Disposition of Febrile Infants ≤60 Days of Age.

Alexander J Rogers1, Nathan Kuppermann2, Jennifer Anders3, Genie Roosevelt4, John D Hoyle5, Richard M Ruddy6, Jonathon E Bennett7, Dominic A Borgialli8, Peter S Dayan9, Elizabeth C Powell10, T Charles Casper11, Octavio Ramilo12, Prashant Mahajan1.   

Abstract

BACKGROUND: Febrile infants commonly present to emergency departments for evaluation.
OBJECTIVE: We describe the variation in diagnostic testing and hospitalization of febrile infants ≤60 days of age presenting to the emergency departments in the Pediatric Emergency Care Applied Research Network.
METHODS: We enrolled a convenience sample of non-critically ill-appearing febrile infants (temperatures ≥38.0°C/100.4°F) ≤60 days of age who were being evaluated with blood cultures in 26 Pediatric Emergency Care Applied Research Network emergency departments between 2008 and 2013. Patients were divided into younger (0-28 days of age) and older (29-60 days of age) cohorts for analysis. We evaluated diagnostic testing and hospitalization rates by infant age group using chi-square tests and by site using analysis of variance.
RESULTS: Four thousand seven hundred seventy-eight patients were eligible for analysis, of whom 1517 (32%) were 0-28 days of age. Rates of lumbar puncture and hospitalization were high (>90%) among infants ≤28 days of age, with chest radiography (35.5%) and viral testing (66.2%) less commonly obtained. Among infants 29-60 days of age, lumbar puncture (69.5%) and hospitalization (64.4%) rates were lower and declined with increasing age, with chest radiography (36.5%) use unchanged and viral testing (52.7%) slightly decreased. There was substantial variation between sites in the older cohort of infants, with lumbar puncture and hospitalization rates ranging from 40% to 90%.
CONCLUSIONS: The evaluation and disposition of febrile infants ≤60 days of age is highly variable, particularly among infants who are 29-60 days of age. This variation demonstrates an opportunity to modify diagnostic and management strategies based on current epidemiology to safely decrease invasive testing and hospitalization.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  fever; guidelines infant; infectious disease; practice variation

Mesh:

Substances:

Year:  2019        PMID: 31014970      PMCID: PMC6589384          DOI: 10.1016/j.jemermed.2019.03.003

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  36 in total

1.  Utility of the peripheral blood white blood cell count for identifying sick young infants who need lumbar puncture.

Authors:  Bema K Bonsu; Marvin B Harper
Journal:  Ann Emerg Med       Date:  2003-02       Impact factor: 5.721

2.  Influenza virus infection and the risk of serious bacterial infections in young febrile infants.

Authors:  William I Krief; Deborah A Levine; Shari L Platt; Charles G Macias; Peter S Dayan; Joseph J Zorc; Nancy Feffermann; Nathan Kuppermann
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

3.  Gene expression patterns in blood leukocytes discriminate patients with acute infections.

Authors:  Octavio Ramilo; Windy Allman; Wendy Chung; Asuncion Mejias; Monica Ardura; Casey Glaser; Knut M Wittkowski; Bernard Piqueras; Jacques Banchereau; A Karolina Palucka; Damien Chaussabel
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

4.  Changing epidemiology of serious bacterial infections in febrile infants without localizing signs.

Authors:  Kevin Watt; Erica Waddle; Ravi Jhaveri
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

5.  Practice variations in the treatment of febrile infants among pediatric emergency physicians.

Authors:  Ran D Goldman; Dennis Scolnik; Laurel Chauvin-Kimoff; Ken J Farion; Samina Ali; Tim Lynch; Serge Gouin; Martin H Osmond; David W Johnson; Terry P Klassen
Journal:  Pediatrics       Date:  2009-07-20       Impact factor: 7.124

6.  Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections.

Authors:  Deborah A Levine; Shari L Platt; Peter S Dayan; Charles G Macias; Joseph J Zorc; William Krief; Jeffrey Schor; David Bank; Nancy Fefferman; Kathy N Shaw; Nathan Kuppermann
Journal:  Pediatrics       Date:  2004-06       Impact factor: 7.124

7.  Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections.

Authors:  Carrie L Byington; F Rene Enriquez; Charles Hoff; Richard Tuohy; E William Taggart; David R Hillyard; Karen C Carroll; John C Christenson
Journal:  Pediatrics       Date:  2004-06       Impact factor: 7.124

8.  Is a chest radiograph necessary in the evaluation of every febrile infant less than 8 weeks of age?

Authors:  E F Crain; D Bulas; P E Bijur; H S Goldman
Journal:  Pediatrics       Date:  1991-10       Impact factor: 7.124

9.  Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone.

Authors:  M N Baskin; E J O'Rourke; G R Fleisher
Journal:  J Pediatr       Date:  1992-01       Impact factor: 4.406

10.  Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department.

Authors:  Barbara Andreola; Silvia Bressan; Silvia Callegaro; Anna Liverani; Mario Plebani; Liviana Da Dalt
Journal:  Pediatr Infect Dis J       Date:  2007-08       Impact factor: 2.129

View more
  8 in total

1.  Comparing Patterns of Care for Febrile Infants at Community and University-Affiliated Hospitals.

Authors:  Rachel Cane; Ellen Kerns; Lauren Maskin; Beth Natt; Lisa Sieczkowski; Eric Biondi; Russell J McCulloh
Journal:  Hosp Pediatr       Date:  2021-03

2.  Use of Procalcitonin in a Febrile Infant Clinical Pathway and Impact on Infants Aged 29 to 60 Days.

Authors:  Kaitlin Widmer; Sarah Schmidt; Leigh Anne Bakel; Michael Cookson; Jan Leonard; Amy Tyler
Journal:  Hosp Pediatr       Date:  2021-03

3.  Prevalence of Bacterial Meningitis Among Febrile Infants Aged 29-60 Days With Positive Urinalysis Results: A Systematic Review and Meta-analysis.

Authors:  Brett Burstein; Vikram Sabhaney; Jeffrey N Bone; Quynh Doan; Fahad F Mansouri; Garth D Meckler
Journal:  JAMA Netw Open       Date:  2021-05-03

4.  Development of a Parent-Reported Outcome Measure for Febrile Infants ≤60 Days Old.

Authors:  Paul L Aronson; Eduardo Fleischer; Paula Schaeffer; Liana Fraenkel; Mary C Politi; Marney A White
Journal:  Pediatr Emerg Care       Date:  2022-02-01       Impact factor: 1.454

5.  Variation in hospital admission in febrile children evaluated at the Emergency Department (ED) in Europe: PERFORM, a multicentre prospective observational study.

Authors:  Dorine M Borensztajn; Nienke N Hagedoorn; Irene Rivero Calle; Ian K Maconochie; Ulrich von Both; Enitan D Carrol; Juan Emmanuel Dewez; Marieke Emonts; Michiel van der Flier; Ronald de Groot; Jethro Herberg; Benno Kohlmaier; Emma Lim; Federico Martinon-Torres; Daan Nieboer; Ruud G Nijman; Marko Pokorn; Franc Strle; Maria Tsolia; Clementien Vermont; Shunmay Yeung; Dace Zavadska; Werner Zenz; Michael Levin; Henriette A Moll
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

6.  Practice variation across five European paediatric emergency departments: a prospective observational study.

Authors:  Fabienne Ropers; Patrick Bossuyt; Ian Maconochie; Frank J Smit; Claudio Alves; Susanne Greber-Platzer; Henriette A Moll; Joany Zachariasse
Journal:  BMJ Open       Date:  2022-03-31       Impact factor: 2.692

7.  Disparities and implicit bias in the management of low-risk febrile infants: a mixed methods study protocol.

Authors:  Colleen K Gutman; K Casey Lion; Paul Aronson; Carla Fisher; Carma Bylund; Antionette McFarlane; Xiangyang Lou; Mary D Patterson; Ahmed Lababidi; Rosemarie Fernandez
Journal:  BMJ Open       Date:  2022-09-20       Impact factor: 3.006

8.  Procalcitonin at 12-36 hours of fever for prediction of invasive bacterial infections in hospitalized febrile neonates.

Authors:  Anne-Sophie Romain; Romain Guedj; Anais Chosidow; Nicolas Mediamolle; Aurélie Schnuriger; Sophie Vimont; Charlène Ferrandiz; Nicolas Robin; Marie-Hélène Odièvre; Emmanuel Grimprel; Mathie Lorrot
Journal:  Front Pediatr       Date:  2022-09-29       Impact factor: 3.569

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.